Green Thumb Industries (GTBIF) Change in Account Payables (2019 - 2026)
Green Thumb Industries (GTBIF) posted Change in Account Payables of -$4.6 million for Q1 2026, down 1095.85% on a QoQ basis from -$386000.0 in Q4 2025, and up 15.44% year-over-year from -$4.0 million in Q1 2025.
Green Thumb Industries (GTBIF) Change in Account Payables (2019 - 2026) Analysis & Trends
Green Thumb Industries' Change in Account Payables history runs 8 years deep, the most recent figure standing at -$4.6 million for Q1 2026.
- Quarterly Change in Account Payables rose 15.44% year-over-year to -$4.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $887000.0 (up 110.39% YoY) and the FY2025 annual result came in at $44000.0, down 83.82% from the prior year.
- Change in Account Payables was -$4.6 million for Q1 2026 at Green Thumb Industries, down from -$386000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $10.6 million in Q2 2023 and bottomed at -$9.6 million in Q3 2024.
- A 5-year average of $314294.1 and a median of $1.6 million in 2024 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2023 — Change in Account Payables soared 380.4% — and 2025, when it tumbled 263.1%.
- Green Thumb Industries' Change in Account Payables stood at $3.8 million in 2022, then sank by 48.09% to $2.0 million in 2023, then soared by 147.43% to $4.9 million in 2024, then tumbled by 107.85% to -$386000.0 in 2025, then tumbled by 1095.85% to -$4.6 million in 2026.
- Business Quant data shows GTBIF's Change in Account Payables at -$4.6 million in Q1 2026, -$386000.0 in Q4 2025, and $2.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | -4.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.62 Mn |
| Mar 31, 2026 | -4.62 Mn |
| Dec 31, 2025 | -386,000.00 |
| Dec 31, 2025 | -386,000.00 |
| Sep 30, 2025 | 2.13 Mn |
| Sep 30, 2025 | 2.13 Mn |
| Jun 30, 2025 | 3.76 Mn |
| Jun 30, 2025 | 3.76 Mn |
| Mar 31, 2025 | -5.46 Mn |
| Mar 31, 2025 | -5.46 Mn |
| Dec 31, 2024 | 4.92 Mn |
| Dec 31, 2024 | 4.92 Mn |
| Sep 30, 2024 | -9.59 Mn |
| Sep 30, 2024 | -9.59 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 3.35 Mn |
| Mar 31, 2024 | 3.35 Mn |
| Dec 31, 2023 | 1.99 Mn |
| Dec 31, 2023 | 1.99 Mn |